Jennifer Woyach

54PUBLICATIONS
282CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsLiquid biopsiesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (54)

|Aug 24, 2026
T-cell immunosenescence limits CD19 CAR T-cell function in chronic lymphocytic leukemia.

|Jul 14, 2026
Safety and Clinical Outcomes of a First-in-Human Trial of Point-of-Care Manufactured Trispecific CAR T Cells Targeting CD19, CD20, and CD22.

|Apr 22, 2026
Single-Cell RNA-seq Analysis Reveals Distinct Tumor and Immunosuppressive T-Cell Phenotypes in Patients with CLL Treated with Ibrutinib.

|Mar 31, 2026
Final phase 2 study results of acalabrutinib in treatment-naive and relapsed/refractory chronic lymphocytic leukemia.

Richard R Furman, William G Wierda, Piers Em Patten

|Mar 06, 2026
Enhancing tyrosine kinase inhibitor sensitivity by restoring IKAROS activity on GLUT1 expression and glycolysis in Philadelphia chromosome-positive acute lymphoblastic leukemia.

Linyao Zhang, Qi Han, Huimin Xiang

|Feb 23, 2026
Safety and clinical outcomes of a first-in-human trial of point-of-care manufactured trispecific CAR T cells targeting CD19, CD20, and CD22.

Sumithira Vasu, Nathan Denlinger, No-Joon Song

Pageof 9

Frequent Collaborators

12 joint publications

Paolo Ghia

10 joint publications

Adam S Kittai

8 joint publications

Kerry A Rogers

8 joint publications

John C Byrd